• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人类诱导多能干细胞对高、低多基因风险的常见阿尔茨海默病进行建模:一项大规模研究资源。

Modeling common Alzheimer's disease with high and low polygenic risk in human iPSC: A large-scale research resource.

作者信息

Maguire Emily, Winston Jincy, Ellwood Sarah H, O'Donoghue Rachel, Shaw Bethany, Morales Atahualpa Castillo, Keat Samuel, Evans Alexandra, Marshall Rachel, Luckcuck Lauren, Brown Laura, Salis Elisa, Leonenko Ganna, Denning Nicola, Allen Nicholas D, Escott-Price Valentina, Webber Caleb, Taylor Philip R, Sims Rebecca, Cowley Sally A, Williams Julie, Carpanini Sarah M, Hall-Roberts Hazel

机构信息

UK Dementia Research Institute at Cardiff University, Maindy Road, CF24 4HQ Cardiff, UK.

James and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, OX1 3RE Oxford, UK.

出版信息

Stem Cell Reports. 2025 Aug 12;20(8):102570. doi: 10.1016/j.stemcr.2025.102570. Epub 2025 Jul 3.

DOI:10.1016/j.stemcr.2025.102570
PMID:40614728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12365843/
Abstract

Common forms of Alzheimer's disease (AD) are complex and polygenic. We have created a research resource that seeks to capture the extremes of polygenic risk in a collection of human induced pluripotent stem cell (iPSC) lines from over 100 donors: the IPMAR Resource (iPSC Platform to Model Alzheimer's Disease Risk). Donors were selected from a large UK cohort of 6,000+ research-diagnosed early or late-onset AD cases and elderly cognitively healthy controls, many of whom have lived through the age of risk for disease development (>85 years). We include iPSC with extremes of global AD polygenic risk (high-risk late-onset AD: 34; high-risk early-onset AD: 29; low-risk control: 27) as well as those reflecting complement pathway-specific genetic risk (high-risk AD: 9; low-risk controls: 10). All iPSC have associated clinical, longitudinal, and genetic datasets and will be available through collaboration or from cell (EBiSC) and data (DPUK) repositories.

摘要

常见形式的阿尔茨海默病(AD)是复杂的多基因疾病。我们创建了一个研究资源库,旨在从100多名捐赠者的人类诱导多能干细胞(iPSC)系集合中捕捉多基因风险的极端情况:IPMAR资源库(模拟阿尔茨海默病风险的iPSC平台)。捐赠者选自英国一个由6000多名经研究诊断为早发性或晚发性AD病例以及认知健康的老年对照组成的大型队列,其中许多人已度过疾病发展的风险年龄(>85岁)。我们纳入了具有全球AD多基因风险极端情况的iPSC(高风险晚发性AD:34个;高风险早发性AD:29个;低风险对照:27个)以及那些反映补体途径特异性遗传风险的iPSC(高风险AD:9个;低风险对照:10个)。所有iPSC都有相关的临床、纵向和遗传数据集,可通过合作或从细胞(EBiSC)和数据(DPUK)储存库获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/22ecf4d0ab3c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/9ffae4775fd5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/8a8730dc6280/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/22ecf4d0ab3c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/9ffae4775fd5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/8a8730dc6280/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5942/12365843/22ecf4d0ab3c/gr3.jpg

相似文献

1
Modeling common Alzheimer's disease with high and low polygenic risk in human iPSC: A large-scale research resource.利用人类诱导多能干细胞对高、低多基因风险的常见阿尔茨海默病进行建模:一项大规模研究资源。
Stem Cell Reports. 2025 Aug 12;20(8):102570. doi: 10.1016/j.stemcr.2025.102570. Epub 2025 Jul 3.
2
Association of genetic risk of Alzheimer's disease and cognitive function in two European populations.两个欧洲人群中阿尔茨海默病遗传风险与认知功能的关联
Sci Rep. 2025 Feb 21;15(1):6410. doi: 10.1038/s41598-025-90277-9.
3
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
4
Genetic predisposition to high circulating levels of interleukin 6 and risk for Alzheimer's disease. Discovery and replication.循环白细胞介素6水平高的遗传易感性与阿尔茨海默病风险。发现与验证。
J Prev Alzheimers Dis. 2025 Jan;12(1):100018. doi: 10.1016/j.tjpad.2024.100018. Epub 2025 Jan 1.
5
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia.诱导多能干细胞模型作为一种研究和测试阿尔茨海默病和额颞叶痴呆液生物标志物的工具。
Brain Pathol. 2024 Jul;34(4):e13231. doi: 10.1111/bpa.13231. Epub 2024 Jan 21.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition.5种疾病的多基因风险评分与阿尔茨海默病进展、生物标志物及淀粉样蛋白沉积的关联
Neurology. 2025 Feb 25;104(4):e210250. doi: 10.1212/WNL.0000000000210250. Epub 2025 Jan 21.
8
Addressing overfitting bias due to sample overlap in polygenic risk scoring.解决多基因风险评分中由于样本重叠导致的过拟合偏差问题。
Alzheimers Dement. 2025 Apr;21(4):e70109. doi: 10.1002/alz.70109.
9
Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.用于识别阿尔茨海默病风险群体的基因分层
J Alzheimers Dis. 2017;57(1):275-283. doi: 10.3233/JAD-161070.
10
Association of -Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.独立阿尔茨海默病多基因风险评分与无症状老年人大脑淀粉样蛋白沉积的关联。
Neurology. 2022 Aug 1;99(5):e462-e475. doi: 10.1212/WNL.0000000000200544.

本文引用的文献

1
Modeling sporadic Alzheimer's disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors.通过将载脂蛋白E4风险基因与环境风险因素相结合在小鼠中模拟散发性阿尔茨海默病
Front Aging Neurosci. 2024 Feb 27;16:1357405. doi: 10.3389/fnagi.2024.1357405. eCollection 2024.
2
APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.载脂蛋白 E 基因型与年龄、性别和人群种族的阿尔茨海默病风险。
JAMA Neurol. 2023 Dec 1;80(12):1284-1294. doi: 10.1001/jamaneurol.2023.3599.
3
Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer's disease patients.
利用来自阿尔茨海默病患者的大量个体诱导多能干细胞系样本剖析神经元淀粉样前体蛋白生成的多基因结构。
Nat Aging. 2022 Feb;2(2):125-139. doi: 10.1038/s43587-021-00158-9. Epub 2022 Feb 17.
4
A Trem2 mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques.Trem2 敲除小鼠模型在应对斑块时会驱动年龄和疾病依赖性的组织损伤和突触丢失,且不存在隐性剪接。
Mol Neurodegener. 2023 Feb 17;18(1):12. doi: 10.1186/s13024-023-00598-4.
5
New insights into the genetic etiology of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症的遗传学病因新见解。
Nat Genet. 2022 Apr;54(4):412-436. doi: 10.1038/s41588-022-01024-z. Epub 2022 Apr 4.
6
A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome.阿尔茨海默病的当前哺乳动物模型综述及需克服的挑战
Int J Mol Sci. 2021 Dec 6;22(23):13168. doi: 10.3390/ijms222313168.
7
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors.干细胞衍生的神经元反映了其年老供体的蛋白质网络、神经病理学和认知结果的特征。
Neuron. 2021 Nov 3;109(21):3402-3420.e9. doi: 10.1016/j.neuron.2021.08.003. Epub 2021 Sep 1.
8
Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n = 3) and sex- and age-matched healthy controls (n = 3).从患有家族性阿尔茨海默病的患者(n=3)和性别及年龄匹配的健康对照者(n=3)中生成 6 个人类 iPSC 系。
Stem Cell Res. 2021 May;53:102379. doi: 10.1016/j.scr.2021.102379. Epub 2021 Apr 30.
9
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease.补体基因对迟发性阿尔茨海默病发病风险的影响。
Genes (Basel). 2021 Mar 20;12(3):443. doi: 10.3390/genes12030443.
10
Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?迟发性与非孟德尔早发性阿尔茨海默病:有区别吗?
Neurol Genet. 2020 Oct 6;6(5):e512. doi: 10.1212/NXG.0000000000000512. eCollection 2020 Oct.